Emblem Corp. (TSXV: EMC, OTCQX: EMMBF), through its wholly-owned subsidiary Emblem Cannabis Corporation, a licensed producer of medical cannabis under the Access to Cannabis for Medical Purposes Regulations (“ACMPR”), today announced that it has entered into a five-year wholesale supply agreement with Aphria Inc. (TSX: APH, US OTC: APHQF).
Empower Clinics Inc. (CSE: EPW; FRA: 8EC), a leading owner and operator of medical cannabis and wellness clinics in the US, today announced that it has established a new clinic in downtown Chicago, as part of the company’s national expansion.
Aurora Cannabis Inc. (TSX: ACB) (OTCQB: ACBFF) (Frankfurt: 21P; WKN: A1C4WM) today announced that it has acquired Europe's largest producer, processor and supplier of certified organic hemp and hemp products, Agropro UAB, as well as hemp processor and distributor Borela UAB.
Namaste Technologies Inc. (TSXV: N) (FRANKFURT: M5BQ) (OTCMKTS: NXTTF) is pleased to announce that further to its July 23rd news release, the Company intends to continue to pursue the listing of its common shares on the NASDAQ Capital Market.
InMed Pharmaceuticals Inc. (TSX:IN; OTCQX:IMLFF), today announced that the Company's research partner, University of British Columbia, has been approved to receive a grant from the Natural Sciences and Engineering Research Council of Canada for their collaborative efforts with InMed in the biosynthesis of cannabinoids.
CannTrust Holdings Inc. ("CannTrust", TSX: TRST), and Breakthru Beverage Group, the largest Canadian beverage alcohol broker of premium spirits, wine and beer brands, have announced the execution of a letter of intent for an exclusive partnership to represent CannTrust's specialty products to Canadian adult consumers for recreational use.
The Supreme Cannabis Company, Inc. (TSXV: FIRE) (OTCQX: SPRWF) (FRA: 53S1), announced that the Company's wholly owned subsidiary, 7ACRES, has entered into a supply agreement to provide dried cannabis to Tilray Canada Ltd., a subsidiary of Tilray Inc. (NASDAQ: TLRY), a global leader in cannabis research, cultivation, processing and distribution currently serving tens of thousands of patients in 11 countries spanning 5 continents.
Aurora Cannabis Inc. (TSX: ACB) (OTCQB: ACBFF) (Frankfurt: 21P; WKN: A1C4WM) and ICC Labs Inc. (TSX-V: ICC) (ICC) announced today that the companies have entered into a definitive arrangement agreement pursuant to which Aurora intends to acquire all of the issued and outstanding common shares of ICC for $1.95 per share (payable in common shares of Aurora, reflecting an aggregate purchase price of approximately $290 million.
Aphria clears balance sheet of U.S. cannabis investments and will reenter U.S. market when U.S. federal laws permit
MedMen Enterprises Inc. (CSE: MMEN) (OTCQB: MMNFF) (FSE: A2JM6N), announced today it has secured prime retail locations with long term leases in Ft. Lauderdale, Miami Beach, West Palm Beach, St. Petersburg and Key West. The company continues to expand its footprint in premium retail districts with high visibility and heavy foot traffic.
Horizons ETFs Management (Canada) Inc. is pleased to announce that the Horizons Marijuana Life Sciences Index ETF ("HMMJ") has reached CAD $1 billion in assets under management.
The Supreme Cannabis Company (TSXV: FIRE) (OTCQX: SPRWF) (FRA: 53S1), announced that it has obtained Health Canada approval to commence cultivation on approximately 20,000 square feet of additional flowering rooms at its 7ACRES facility.
Aphria Inc. (TSX: APH andUS OTC: APHQF) and Rapid Dose Therapeutics Inc., a Canadian bio-technology company focused on innovative drug delivery solutions, announced today that they have signed a non-binding Memorandum of Understanding related to RDT's QuickStrip™ products. Under the terms of the MOU, the companies intend to enter into a definitive agreement in the near future pursuant to which RDT will provide Aphria with exclusive global preferred rights to produce, distribute and sell QuickStrip™ products for cannabis markets around the world.
Aurora Cannabis Inc. (TSX: ACB) (OTCQB: ACBFF) (Frankfurt: 21P; WKN: A1C4WM) today announced that it has closed its previously announced debt facility with the Bank of Montreal.
The Flowr Corporation is pleased to announce that it has closed its offering of subscription receipts of Flowr, which was oversubscribed and raised approximately $C36 million. The offering is a further step toward completing the Company’s previously announced plan to effect a reverse takeover of The Needle Capital Corp., which is anticipated to occur on or before September 10.
